PABME

Supporting Sponsor

Industry Event

 Exhibit at the Show  Attend as a Visitor  Be a Sponsor  Be a Sponsor
 


Exclusively for PABME’s Participants
Now You Can Have Healthcare & Pharmaceuticals Research Products
Featuring Primary Data, Independent Analysis and Fresh Opinions on
Markets, Trends and Players for a Lower Price!

Yes! By being a part of PABME whether as an exhibitor, conference delegate or a
visitor now you can have access to the following industry reports that will help your
business being informed at a special discount of 10%... that’s a lot of savings for
reports that will definitely keep you up-to-date with what’s going on in the market!

Click on any of the following reports for more information. Remember to quote your VIP code (PB09DM) at the checkout to receive the special discount.
If you would like further information about the reports or how Datamonitor's research
or consulting practices might help you, please either call Imran Ahmed
at +971 4 407 2720, +971 50 881 8495 or e-mail iahmed@datamonitor.com.
 

Title

Format

Chinese Pharmaceutical Market Overview - Regulatory reform and the evolving healthcare market provide opportunities in china

PDF & SlidePack

 

 

Pipeline Insight: Non-insulin Antidiabetics - Type 2 diabetes unlikely to develop into a switch market

PDF + Slidepack

 

 

Reformulation Strategies - Comparisons of Past and Future Reformulation Strategies

PDF + SlidePack

 

 

Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies - More drugs on the market, more targets in the pipeline

PDF + SlidePack + Datapack

 

 

Commercial and Pipeline Perspectives: Obesity - Lack of Reimbursement Limits Market Potential

PDF

 

 

Pipeline Insight: Osteoarthritis - The Wait for a DMOAD Continues

PDF & SlidePack

 

 

Stakeholder Insight: Alzheimer's Disease - Prescribing trends indicate that neurologists are not adhering to guidelines

PDF & SlidePack

 

 

Biosimilars: Regulatory Issues - Europe continues to make strides while the US lags behind

PDF

 

 

Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma -  Limited R&D activity provides opportunity for early-phase pipeline drugs

PDF

 

 

The Pharmaceutical Industry: Key trends and strategic issues shaping the industry.

PDF & SlidePack

 

 

Pipeline Insight: Depression - Novel drugs to grow third-line market

PDF

 

 

Stakeholder Opinions: Fibromyalgia - Potentially lucrative market soon to become reality

PDF & SlidePack

 

 

Pipeline Insight: Antithrombotics - Reaching the untreated prophylaxis market

PDF

 

 

Pipeline Insight: Dyslipidemia - Pipeline agents unlikely to rejuvenate the market

PDF

 

 

Pricing & Reimbursement Series: Medicare Part D's progress so far

PDF & SlidePack

 

 

Generic Series: Benchmarking Patent Expiries - Key Factors Affecting Brand Erosion at Patent Expiry

PDF & SlidePack

 

 

Monoclonal Antibodies Report Part I

PDF & SlidePack

 

 

Stakeholder Opinions: Irritable Bowel Syndrome - Potentially profitable market is open for the taking

PDF

 

 

Generic Series: An Introduction to the Canadian Generics Market - Key trends and leading companies shaping the market

PDF

 

 

Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies overtake cytotoxics in 2006

PDF & SlidePack & DataPack

 

 

Monoclonal Antibodies Report Part II: Companies - Holding mAbs in portfolio promises protection against the looming 2011-12 patent cliff

PDF

 

 

Pipeline and Commercial Insight: Pediatric and Adolescent Vaccines

PDF & SlidePack & DataPack

 

 

Stakeholder Opinions: Primary Brain Cancer

PDF

 

 

Stakeholder Opinions: Female Sexual Dysfunction - Results from Datamonitor's 2005 physician survey

PDF

 

 

Business Blogging for Pharma

PDF

 

 

Biosimilars Series: Regulatory and development issues  hurdles exist but are surmountable

PDF & SlidePack